The size of Europe's Soy Isoflavones Market is expected to be worth USD 0.41 billion in 2024 and grow at a CAGR of 4.39% from 2024 to 2029 to achieve USD 0.51 billion by 2029.
Isoflavones are phytoestrogens that have a similar chemical structure to the hormone estrogen, and isoflavones also have estrogens or anti-estrogenic effects, so it is considered SERM (Selective Estrogen Receptor Modulators). The soy Isoflavones are potentially a very rich source of estrogen and vitamin E and possess properties like anti-oxidants and breast cancer cell suppressors. The soy Isoflavones are produced from the leaf, bark, seed, and shell of soy plants, and the end products of soy Isoflavones can be made available in the form of powder, oil, or wax. The increasing awareness about the consumption of soy Isoflavones in the diet and its benefits, like prevention and cure of heart-related diseases, multiple cancers, asthma, and diabetes, are the major factors driving the demand for soy Isoflavones worldwide.
The Europe soy Isoflavones market is anticipated to register a considerable CAGR over the aforementioned forecast period owing to the increasing demand for soy Isoflavones from the pharmaceutical and medical industry. Soy Isoflavones have properties like antioxidants along with protecting against bad cholesterol and atherosclerosis in cardiovascular diseases, thereby driving the demand for the soy Isoflavones market. The consumption of soy Isoflavones through food and food supplements reduces the risk of the growth of cancer cells by reducing the cell mitosis process. The growing demand for soy Isoflavones from the cosmetics industry protects against sun damage, treats skin firming and wrinkles, and moisturizes skin, which also drives the Europe soy Isoflavones market.
But still, the overconsumption of soy Isoflavones leads to the side effects like migraine, food allergies, and thyroid disorder and may hinder the use of the soy Isoflavones and restrain the Europe soy Isoflavones market.
Europe is also emerging as a potential market for the same because of its various health benefits. It is likely to witness significant growth in the aforementioned forecast period.
Major Key Players in Europe's Soy Isoflavones Market are Fujicco Co., Ltd, Aushadhi Herbal, Tradichem S.L, Frutarom Ltd., Archer Daniels Midland, SK Bioland, Medisys Biotech Pvt. Ltd., Guzen Development, Nutra Green Biotechnology Co., Ltd., and HerboNutra
Frequently Asked Questions
Some current trends include increased consumer awareness about health benefits, rising demand for natural ingredients, and the growing popularity of plant-based diets.
The market is anticipated to experience steady growth due to increasing consumer health consciousness, rising adoption of soy-based products, and ongoing research highlighting the health benefits of soy isoflavones.
The innovations in food processing techniques, product formulations, and packaging drive growth by enhancing the quality, convenience, and appeal of soy isoflavone products to consumers.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region